Navigation Links
Informed Medical Communications Adopts Newly Enhanced Compliance Policy
Date:6/23/2008

EDISON, N.J., June 23 /PRNewswire/ -- Informed Medical Communications (IMC), a leading provider of peer-to-peer medical forums for the bio-pharmaceutical industry, today announced adoption of an enhanced compliance policy and the appointment of Dr. Jaime Nguyen as Medical Director/ Compliance Officer (CO). The policy specifically outlines the role of the CO as well as methods for handling written policies/procedures, training/education, internal monitoring/auditing, reporting/lines of communication, and prompt response and corrective action for violations and detected problems. "The changes reflect IMC's commitment to compliance with the laws, regulations, and guidelines that govern pharmaceutical promotional and marketing activities," said Steve Budd, CEO of IMC. "Our ongoing investment in this critical competency will enable us to partner more closely with our clients to ensure that the medical communications programs we execute on their behalf meet the highest standards for promotional compliance."

(Logo: http://www.newscom.com/cgi-bin/prnh/20080512/NYM105LOGO )

Dr. Nguyen was appointed to this position following two years of distinguished service as a moderator on numerous IMC programs. Nguyen holds an MD from MSIH and Columbia University Medical Center, an MPH from the University of Pittsburgh, and an MS in Medicinal Chemistry and Pharmacology from the University of Toledo. Additionally, Nguyen is a certified Pharmaceutical, Biotech and Medical Device Compliance Officer. Prior to joining IMC in 2006, Nguyen had over 10 years of experience in the areas of pharmacology and drug design, medicine and public health, and healthcare analysis. She also held numerous international clinical leadership roles across multiple therapeutic areas and served on two federal advisory committees while working for the Department of Health and Human Services.

"In the current highly regulated environment, and consistent with our ongoing focus on mitigating risk for our clients, a comprehensive Compliance Policy and dedicated CO are essential," noted Kathleen Bresette, President of The Peer Group (an IMC company). "We are delighted to have someone with Jaime's qualifications and enthusiasm supporting IMC and our clients in this capacity."

IMC's Compliance Policy may be found on the IMC website.

About Informed Medical Communications

Informed Medical Communications (http://www.informedmedical.com), headquartered in Edison, NJ, is an interactive medical marketing group of companies providing services to the biopharmaceutical industry. The companies include The Peer Group and RxDialogue, industry innovators and leaders in conducting general and specialty peer-to-peer medical programs, respectively. Additionally, IMC's major businesses are enhanced by MRxHealth, the market research and consulting infrastructure that supports IMC's ongoing development and effectiveness of non-traditional marketing programs for biopharmaceutical clients, and Leading Through Dialogue, a communications training service for elite skill development in three areas: (1) leadership, (2) sales, and (3) training/facilitation. The IMC network of companies delivers integrated marketing programs for pharmaceutical marketers, with the goal of improving the dialogue among healthcare practitioners in understanding health conditions and their medical options. IMC is a private-equity backed, privately held company.


'/>"/>
SOURCE Informed Medical Communications
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Informed Medical Communications Appoints Charles T. Saldarini to Board of Directors
2. InnovationRx, a Prescription Adherence Solutions Company, and InforMedix Partner to Market and Sell End-to-End Medication Adherence Solutions
3. Informed Medical Communications Hires New Vice President of Marketing
4. Informed Medical Communications Appoints New Chief Financial Officer
5. AEterna Zentaris completes management team with the appointment of Chief Medical Officer
6. VisEn Medical Files Action to Invalidate New Caliper Life Sciences Patent
7. China Medical Technologies to Participate in the Morgan Stanleys 2007 China Medical Corporate Day
8. Pathway Medical Technologies Adds Joe Rafferty as VP, Sales, and Moves To Larger Facility to Accommodate Rapid Growth
9. BioMS Medical announces its intention to renew a normal course issuer bid
10. Dr. Amit Dhawan Promoted to Medical Director for The Mattson Jack Group
11. ATS Medical Expands Open Pivot Heart Valve Offerings
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/24/2017)...   Sienna Biopharmaceuticals, Inc. , a privately held, ... Richard Peterson will join the company as ... who brings more than two decades of global financial ... retiring at the end of April but will continue ... Sienna from Novan, Inc., where he served as Chief ...
(Date:3/23/2017)... ... 2017 , ... AxioMed president, Jake Lubinski, describes the AxioMed ... deformed, which is identical to how the human discs work to distribute force. ... to its natural state along a hysteresis curve, exactly like a healthy human ...
(Date:3/23/2017)... DUBLIN , Mar 23, 2017 ... "Biorefinery Products: Global Markets" report to their offering. ... The ... from $466.6 Billion in 2016 at a CAGR of 8.9%, ... of energetic and non-energetic bioproducts into seven major product segments: ...
(Date:3/23/2017)... March 23, 2017  SeraCare Life Sciences, ... in vitro diagnostics manufacturers and clinical laboratories, ... first multiplexed Inherited Cancer reference material ... by next-generation sequencing (NGS). The Seraseq™ Inherited Cancer ... input from industry experts to validate the ...
Breaking Biology Technology:
(Date:3/6/2017)... 6, 2017 Mintigo , the ... announced Predictive Sales Coach TM , its new ... intelligence into Salesforce. This unique AI application will ... organizations with deep knowledge of their customers and ... engagement. Predictive Sales Coach extends Mintigo,s existing customer ...
(Date:3/2/2017)... -- Australian stem cell and regenerative medicine company, ... agreement with the Monash Lung Biology Network, a consortia ... Department of Pharmacology at Monash University, Melbourne ... support the use of Cymerus™ mesenchymal stem cells (MSCs) ... is a chronic, long term lung condition recognised by ...
(Date:2/28/2017)...  EyeLock LLC, ein marktführendes Unternehmen im Bereich ... Lösung zur Iris-Erkennung auf der neuesten Mobilplattform ... dem Mobile World Congress 2017 (27. Februar ... 3, Stand 3E10, vorstellen. Der ... – eine Kombination aus Hardware, Software und ...
Breaking Biology News(10 mins):